Human Development

End-of-life care: hospice eligibility and referral

Clinical Overview and When to Suspect Hospice Eligibility

— Two physicians certify life expectancy ≤6 months (attending + hospice medical director for initial certification)

— Patient (or surrogate) signs election statement accepting palliative rather than curative intent

— Care delivered by a Medicare-certified hospice agency

— Advanced, progressive, life-limiting illness despite optimal disease-directed therapy

— Functional decline: declining Palliative Performance Scale (PPS ≤70%), Karnofsky ≤50%, or ECOG ≥3

— The "surprise question": "Would I be surprised if this patient died in the next 12 months?" If No, initiate goals-of-care discussion and consider hospice

— Recurrent hospitalizations or ED visits for the same advanced condition

— Progressive weight loss (>10% in 6 months), albumin <2.5, recurrent infections, pressure injuries, dysphagia

Definition: Hospice is a Medicare Part A benefit providing interdisciplinary palliative care for patients with a terminal illness and a prognosis of ≤6 months if the disease follows its expected course, who elect to forgo curative therapy for the terminal diagnosis.

Core eligibility criteria (Medicare Hospice Benefit):

When to suspect a patient is hospice-appropriate:

Common qualifying diagnoses: metastatic cancer, end-stage heart failure (NYHA IV), COPD with rest dyspnea and FEV1 <30%, ESRD off dialysis, advanced dementia (FAST stage 7), ALS, end-stage liver disease (Child-Pugh C), HIV with poor functional status, debility/failure to thrive with comorbidities.

Step 3 management: In the outpatient clinic, the family physician is often the first to identify hospice eligibility. Initiate the conversation early — average US hospice length of stay is only ~17 days, but the benefit is most effective when used for weeks-to-months.

Board pearl: Hospice is a philosophy of care, not a place — 80% of hospice care occurs in the patient's home. Patients can receive hospice in homes, nursing facilities, assisted living, or inpatient hospice units depending on need.

Presentation Patterns and Key History

— Elderly patient with metastatic cancer declining further chemotherapy

— NYHA IV heart failure with EF 15%, multiple recent admissions despite GDMT

— FAST 7c dementia: nonambulatory, <6 intelligible words/day, incontinent, with new aspiration pneumonia

— COPD patient on continuous O2, FEV1 25%, cor pulmonale, unintentional weight loss

— ALS with vital capacity <30% predicted, declining PEG/BiPAP

— Trajectory of decline: hospitalizations in past 6–12 months, ED visits, ICU stays, functional loss (ADL/IADL dependence)

— Disease-specific markers: weight loss %, recurrent infections (UTI, aspiration PNA), pressure injuries stage 3–4, dysphagia, falls

— Symptom burden: pain, dyspnea, nausea, anxiety, delirium, fatigue

— Patient values and goals: "What does a good day look like?" "What are you hoping for?" "What worries you most?"

— Code status, advance directive, healthcare proxy/POA, MOLST/POLST

— Caregiver capacity and home environment — critical because most hospice care is home-based

— SPIKES for delivering serious news: Setting, Perception, Invitation, Knowledge, Empathy, Strategy

— Ask-Tell-Ask for information exchange

— NURSE for emotion: Name, Understand, Respect, Support, Explore

Typical Step 3 vignette triggers:

History elements to elicit:

Communication frameworks (high yield):

Key distinction: Distinguish palliative care (any stage of serious illness, concurrent with curative therapy, no prognosis requirement) from hospice (terminal phase, ≤6 months, forgoes curative therapy for terminal dx). A patient receiving chemo with curative intent can have palliative care but cannot elect hospice for that cancer.

Step 3 management: When the vignette describes a patient with advanced illness saying "I don't want to come back to the hospital," the correct next step is usually a goals-of-care conversation and hospice referral, not another diagnostic workup.

Physical Exam Findings and Functional Assessment

— Palliative Performance Scale (PPS): 0–100%. PPS ≤70% suggests hospice eligibility; ≤40% suggests weeks-to-months

— Karnofsky Performance Status: ≤50 = unable to care for self, hospice-appropriate threshold for many dx

— ECOG: 0 (fully active) → 4 (bedbound). ECOG ≥3 signals advanced disease

— FAST scale (dementia): Stage 7a (≤6 words/day) is the entry point for dementia hospice eligibility

— NYHA IV for heart failure; MRC dyspnea 4–5 for COPD

— Cachexia: temporal wasting, loss of subcutaneous fat, sarcopenia

— Pressure injuries stage 3–4, especially sacral/heel — independent mortality predictor

— Oral candidiasis, dysphagia, drooling — risk for aspiration

— Peripheral edema, JVD, hepatomegaly in end-stage HF

— Accessory muscle use, pursed-lip breathing, barrel chest, distant breath sounds in end-stage COPD

— Asterixis, jaundice, ascites, caput medusae, muscle wasting in end-stage liver disease

— Delirium, withdrawal from environment, decreased PO intake as preterminal signs

— Mottling of extremities, Cheyne-Stokes respirations, terminal secretions ("death rattle"), decreased urine output, mandibular breathing, fixed/dilated pupils, profound weakness, unresponsiveness

Functional status drives prognosis more than any single lab. Document at every visit.

Validated scales (memorize for boards):

Exam findings suggesting terminal trajectory:

Signs of imminent death (hours-to-days):

Board pearl: A drop in PPS by ≥20 points over 1–2 months or new inability to perform ≥3 ADLs is a strong trigger for hospice discussion regardless of underlying diagnosis.

Step 3 management: When examining an elderly nursing home patient with advanced dementia and new aspiration pneumonia, document FAST stage and weight trajectory — these directly determine hospice eligibility under CMS Local Coverage Determinations.

Eligibility Documentation — Disease-Specific Criteria

— NYHA class IV symptoms at rest, optimally treated

— EF ≤20% supportive but not required

— Refractory angina or arrhythmia, frequent admissions

— Disabling dyspnea at rest, FEV1 <30% supportive

— Cor pulmonale, hypoxemia (PaO2 ≤55 or SaO2 ≤88% on O2), hypercapnia (PaCO2 ≥50)

— Unintentional weight loss >10% in 6 months, resting tachycardia >100

— 7a: ≤6 intelligible words/day (minimum threshold)

— Plus one comorbidity in past 12 months: aspiration pneumonia, pyelonephritis, septicemia, stage 3–4 pressure ulcer, recurrent fever, or weight loss >10% / albumin <2.5

CMS Local Coverage Determinations (LCDs) provide disease-specific guidelines. Documentation must support ≤6-month prognosis.

Cancer: Metastatic or locally advanced disease with declining PPS, weight loss, or refusal/failure of disease-directed therapy. Hospice can coexist with palliative radiation or chemo if intent is symptom relief, not cure.

Heart disease (end-stage):

COPD/lung disease:

Dementia (FAST 7):

Liver disease: Child-Pugh C, INR >1.5, albumin <2.5, plus ascites refractory to diuretics, SBP, hepatorenal syndrome, hepatic encephalopathy, or recurrent variceal bleeding — and not a transplant candidate.

Renal disease: CrCl <10 (or <15 with DM), Cr >8 (>6 with DM), and not pursuing dialysis/transplant.

Stroke/coma: PPS ≤40%, poor PO intake (weight loss >10%, albumin <2.5), refusal of artificial nutrition/hydration.

HIV: CD4 <25 or viral load >100,000 with declining function and opportunistic infections.

ALS: Critically impaired breathing capacity (FVC <30%, declining BiPAP tolerance) or rapid disease progression with nutritional impairment.

Board pearl: "Debility, unspecified" and "adult failure to thrive" are no longer accepted as primary hospice diagnoses by CMS — must specify an organ-system terminal diagnosis.

Step 3 management: Document the specific LCD criterion met plus a narrative on disease trajectory — this protects against audit denial.

The Hospice Referral Process and Benefit Structure

— Step 1: Identify eligibility via clinical assessment + surprise question

— Step 2: Conduct goals-of-care conversation; confirm patient/surrogate understands prognosis and the palliative (non-curative) focus

— Step 3: Obtain attending physician certification of terminal prognosis ≤6 months

— Step 4: Refer to Medicare-certified hospice agency (patient/family can choose)

— Step 5: Hospice medical director provides second certification within 2 days

— Step 6: Patient signs election statement; benefit begins

— Routine home care: ~98% of days; nurse visits, aide, social work, chaplain, MD oversight, medications/equipment related to terminal dx

— Continuous home care: ≥8 hours/day of predominantly nursing care during crisis (uncontrolled symptoms) to avoid hospitalization

— General inpatient care (GIP): Symptom management requiring inpatient setting (intractable pain, dyspnea, delirium); short-term

— Respite care: Up to 5 consecutive days in a facility to relieve family caregivers

Step-by-step referral (CCS-style workflow):

Benefit periods: Two 90-day periods, then unlimited 60-day periods. Face-to-face encounter by hospice physician/NP required before the third benefit period and each subsequent one to recertify.

Four levels of hospice care (high yield):

What hospice covers: all care/medications/equipment related to terminal diagnosis, including 24/7 nursing access, bereavement support for family up to 13 months after death.

What patients keep: Medicare Part B for unrelated conditions (e.g., hospice for cancer ≠ loss of coverage for an unrelated hip fracture repair if pursued).

CCS pearl: When the simulated patient elects hospice, discontinue disease-directed orders for the terminal condition (e.g., stop chemo, scheduled labs, telemetry) and order comfort-focused interventions (opioid PRN, antiemetic, bowel regimen, mouth care, family support).

Board pearl: Patients may revoke hospice at any time and return to standard Medicare benefits — election is not irrevocable.

Goals-of-Care Communication and Shared Decision-Making

— Set the stage: private setting, family/proxy present, no interruptions, sit at eye level

— Assess understanding: "Tell me what you understand about your illness"

— Explore values: "What's most important to you right now?" "What gives your life meaning?" "What would be unacceptable?"

— Share prognosis honestly using ranges ("weeks to months") and warning shots ("I wish I had better news…")

— Make a recommendation based on values — don't simply list options. "Based on what you've told me, I recommend we focus on comfort and refer to hospice."

— Address emotion before facts — NURSE statements

— Asking "Do you want us to do everything?" — too vague, suggests withholding care

— Deferring entirely to family when patient has capacity

— Continuing aggressive interventions without prognostic disclosure

— Promising specific timelines ("you have 3 months")

— Using jargon ("DNR/DNI," "comfort care") without explanation

— Some traditions (certain Orthodox Jewish, Muslim, and other communities) emphasize life prolongation; explore meaning rather than assume

— Use professional medical interpreters, not family, for serious news

— Address spiritual distress with chaplaincy referral

Goals-of-care (GOC) conversation is the gateway to appropriate hospice referral. A failure to have this conversation is a common Step 3 trap answer.

Structured approach:

Common Step 3 communication errors (wrong answers):

Cultural and religious humility:

Surrogate decision-making hierarchy (varies by state, typical order): healthcare POA → spouse → adult children → parents → siblings. Apply substituted judgment (what would the patient want?) before best interest standard.

Key distinction: DNR/DNI ≠ hospice ≠ comfort care. A patient can be full code and on hospice; DNR alone does not constitute a goals-of-care plan. Step 3 questions exploit this confusion.

Step 3 management: When a family says "do everything" but the patient has documented wishes to focus on comfort, the patient's prior expressed wishes prevail — clarify with the family using substituted judgment language.

Symptom Management — Pain and Dyspnea

— Mild: acetaminophen ≤3 g/day in elderly/hepatic; NSAIDs cautiously

— Moderate–severe: morphine is first-line opioid in hospice (oral, SL concentrate, SC, IV). Start morphine 2.5–5 mg PO q4h PRN opioid-naive; titrate by 25–50% for inadequate control

— Renal impairment (CrCl <30): prefer hydromorphone, fentanyl, or methadone — avoid morphine (active metabolite M6G accumulates → neurotoxicity, myoclonus)

— Long-acting: convert to scheduled extended-release once daily requirement stable; keep breakthrough at 10–20% of total daily dose q1–2h PRN

— Always co-prescribe a bowel regimen (senna ± PEG); opioid-induced constipation does not develop tolerance

— Low-dose opioids are first-line: morphine 2.5 mg PO q4h or 1–2 mg SC; reduces air hunger via central mechanism without measurable respiratory depression at these doses

— Fan to face (CN V₂ stimulation) — evidence-based nonpharmacologic

— Supplemental O2 only if hypoxemic; benefit is symptomatic, not prognostic

— Anxiolytic adjunct: lorazepam 0.5–1 mg for anxiety component

— Treat reversible contributors: diuretic for pulmonary edema, thoracentesis for malignant effusion, bronchodilator for COPD

— Reposition, reduce IV fluids, glycopyrrolate 0.2 mg SC q4h (preferred — no CNS penetration) or scopolamine patch

— Counsel family: more distressing to observers than to patient

Pain management (WHO ladder + opioid mainstay in hospice):

Dyspnea (most distressing symptom in end-stage cardiopulmonary disease):

Terminal secretions ("death rattle"):

Board pearl: Properly titrated opioids for dyspnea do not hasten death — multiple studies confirm appropriate symptom-directed dosing is safe. The principle of double effect ethically permits symptom relief even with theoretical risk.

Step 3 management: For a hospice patient with breakthrough pain on 60 mg PO morphine/day, the rescue dose is 6–12 mg PO q1h PRN (10–20% of daily total).

Symptom Management — Nausea, Delirium, Constipation, Anorexia

— Opioid-induced or vestibular: haloperidol 0.5–2 mg PO/SC q6h or prochlorperazine

— Gastric stasis: metoclopramide 5–10 mg before meals (avoid in bowel obstruction)

— Chemo/radiation-related, increased ICP: ondansetron 4–8 mg q8h; dexamethasone 4–8 mg/day for ICP, bowel obstruction, anorexia

— Malignant bowel obstruction: octreotide 100–300 mcg SC TID, dexamethasone, antiemetic; avoid NGT if possible (hospice-discordant)

— Anticipatory/anxiety: lorazepam

— Prophylactic regimen: senna 2 tabs BID + PEG 17 g daily; titrate to soft BM every 1–2 days

— Refractory: methylnaltrexone 8–12 mg SC (peripheral μ-antagonist; doesn't cross BBB, preserves analgesia)

— Always rule out impaction before escalating laxatives

— Identify reversible causes only if consistent with goals: urinary retention, fecal impaction, uncontrolled pain, medication toxicity (especially anticholinergics, benzodiazepines)

— First-line: haloperidol 0.5–2 mg PO/SC q4–6h PRN; chlorpromazine if sedation also desired

— Avoid benzodiazepines as monotherapy — can paradoxically worsen delirium; reserve for benzodiazepine/alcohol withdrawal or refractory agitation

— Counsel families: decreased intake is part of dying, not a cause of suffering. Forced feeding/IV hydration can worsen secretions, edema, dyspnea

— Dexamethasone or megestrol may briefly improve appetite in selected patients but do not prolong survival

— Artificial nutrition (PEG) in advanced dementia does NOT improve survival, aspiration risk, pressure ulcers, or quality of life — AGS strong recommendation against

Nausea/vomiting (target the mechanism):

Constipation (universal on opioids):

Terminal delirium (occurs in up to 80% of dying patients):

Anorexia-cachexia:

Key distinction: Palliative sedation (proportionate sedation for refractory symptoms) is ethically and legally distinct from physician-assisted death; intent is symptom relief, not death.

Board pearl: Haloperidol is the workhorse antiemetic and antidelirium agent of hospice — low-dose, multiple routes, well tolerated.

Special Populations — Elderly, Renal, and Hepatic Impairment

— Polypharmacy review at hospice admission: deprescribe statins, bisphosphonates, tight glycemic agents, antihypertensives at aggressive targets, vitamins, donepezil/memantine if no symptomatic benefit

— Beers criteria heightened: avoid benzodiazepines (delirium, falls), anticholinergics, meperidine

— Start low, go slow with opioids: morphine 2.5 mg PO q4h opioid-naive in frail elder

— Diabetes: liberalize A1c target to 8–9%; discontinue sliding scale; goal is avoiding symptomatic hypo/hyperglycemia, not glucose control

— Avoid morphine and codeine (M6G, M3G metabolites → neurotoxicity, myoclonus, prolonged sedation)

— Preferred opioids: fentanyl (no active metabolites; transdermal or SC) and methadone (hepatic clearance; QTc monitoring; complex conversion — specialist preferred)

— Hydromorphone acceptable with caution

— Gabapentin/pregabalin: reduce dose substantially or discontinue

— Avoid NSAIDs

— Reduce dose and frequency of most opioids; fentanyl preferred (no significant hepatic activation needed for analgesia, though metabolized hepatically — start low)

— Avoid acetaminophen >2 g/day in cirrhosis; avoid NSAIDs (variceal bleed, hepatorenal)

— Lactulose for hepatic encephalopathy continued in hospice if it improves comfort and orientation

— Diuretics: continue for ascites comfort even as goals shift; large-volume paracentesis is appropriate hospice intervention for refractory ascites

— Continue loop diuretics, beta-blockers, ACEi/ARB if they improve symptoms; deprescribe if causing hypotension, fatigue, dizziness

— ICD deactivation conversation is essential — patients should be offered shock deactivation to prevent painful end-of-life shocks (pacing function can remain)

Elderly (most hospice enrollees):

Renal impairment (CrCl <30 or ESRD):

Hepatic impairment (end-stage liver disease):

Heart failure on hospice:

Step 3 management: For an ESRD patient electing hospice with severe cancer pain, switch from morphine to fentanyl transdermal or hydromorphone with renal-adjusted dosing.

Board pearl: Always offer ICD deactivation when transitioning a patient to hospice — it is reversible, painless (magnet or programmer), and respects patient values.

Special Populations — Pediatrics, Pregnancy, and Concurrent Care

— Children <21 enrolled in Medicaid or CHIP can receive hospice services concurrently with curative/disease-directed treatment — unique exception to the adult model

— Eliminates the "either/or" choice that historically delayed pediatric hospice enrollment

— Common pediatric hospice diagnoses: congenital/genetic conditions, neuromuscular disease (SMA, DMD), advanced cancer, severe perinatal conditions, complex CHD

— Developmental tailoring: communication aligned with child's cognitive stage; sibling and parent bereavement support

— For pregnancies with prenatally diagnosed lethal anomalies (trisomy 13/18, anencephaly, bilateral renal agenesis) when family elects to continue pregnancy

— Coordinated OB, neonatology, palliative care; birth plan emphasizes comfort, family bonding, memory-making

— Hospice can begin at birth or transition from NICU

— Maternal–fetal ethics committee involvement

— Maternal autonomy and capacity preserved; opioids and palliative meds dosed with fetal considerations but maternal comfort is not subordinated in late-stage terminal illness

— VA provides comprehensive hospice/palliative care; "We Honor Veterans" program addresses combat-related trauma, moral injury, and exposures (Agent Orange, burn pits) at end of life

— Screen for PTSD, which may resurface as terminal illness reduces coping reserves

— Capacity assessment is task-specific, not global; use supported decision-making

— Caregivers (often paid or family) require explicit inclusion in care planning

Pediatric hospice (Section 2302 of the ACA — "concurrent care"):

Perinatal hospice:

Pregnancy with maternal terminal illness (rare but high-stakes):

Veterans:

Patients with intellectual/developmental disabilities:

Key distinction: The pediatric concurrent care provision is a frequent Step 3 distractor — adults under traditional Medicare hospice cannot receive curative treatment for the terminal diagnosis, but children can. Know this exception.

Board pearl: Perinatal hospice referral should occur at the time of lethal prenatal diagnosis, not after birth — proactive planning improves outcomes for families.

Complications and Adverse Outcomes of Late or Missed Referral

— Inadequate symptom control at end of life

— Higher rates of in-hospital and ICU death (against most patient preferences)

— Increased family/caregiver complicated grief and PTSD

— Lower satisfaction with care

— Higher healthcare costs in final months without commensurate benefit

— Missed bereavement support eligibility (must be on hospice when patient dies)

— Aggressive chemotherapy in last 14 days of life (quality measure of poor care)

— ICU admission in last 30 days for patients with terminal disease and clear prognosis

— CPR in advanced dementia or metastatic disease without prognostic disclosure (rib fractures, anoxic injury, rarely survival to discharge)

— Repeated hospitalizations for symptoms manageable at home

— Opioid-induced neurotoxicity (especially morphine + renal impairment): myoclonus, hyperalgesia, delirium → opioid rotation

— Constipation/impaction from inadequate prophylaxis

— Caregiver burnout → utilize respite benefit (5 days)

— Crisis without escalation plan → ensure 24/7 hospice on-call access is documented and family understands to call hospice before 911

Consequences of late hospice referral (median US LOS ~17 days; ~25% enroll in last 5 days):

Iatrogenic harm at end of life when curative path persists inappropriately:

Hospice-specific adverse events to anticipate:

Common scenario: Family calls 911 for symptom crisis; EMS transports to ED → undermines hospice plan and may trigger unwanted interventions. Mitigation: clear written instructions, MOLST/POLST in home, hospice agency phone number prominent, family education at admission.

Quality measures (Hospice Item Set, Hospice Compare): pain screening and management, dyspnea screening/treatment, opioid-induced constipation prevention, discussion of treatment preferences, spiritual concerns addressed.

Step 3 management: When a hospice patient develops acute agitation, call the hospice agency first for in-home management rather than ED transfer; ED visit is appropriate only if outside hospice plan (e.g., traumatic injury) or for inpatient hospice-level symptom control.

Board pearl: Earlier hospice enrollment in metastatic cancer (Temel 2010 and replications) is associated with equal or longer survival plus better quality of life — hospice is not "giving up."

When to Escalate — Inpatient Hospice, Palliative Consult, and Care Transitions

— Pain uncontrolled despite optimized home regimen

— Intractable nausea/vomiting, dyspnea, agitated delirium

— Wound care or symptom needs exceed home resources

— Imminent death with family unable to manage at home

— Typical stay: a few days; transitions back to routine home care once stabilized

— Acute symptom crisis manageable at home with nursing presence ≥8 hours/day

— Avoids hospitalization while maintaining home setting

— Complex symptom management, family meetings, goals-of-care clarification, ethics dilemmas

— Appropriate at any stage of serious illness, including alongside curative therapy

— Should be requested early in admissions for advanced cancer, advanced HF, ESRD considering dialysis withdrawal, post-arrest with poor prognosis, persistent vegetative state discussions

— Reflexive ED transfer for fever, hypotension, or decreased PO intake when consistent with dying trajectory

— Routine labs, imaging, or telemetry that won't change management

— IV fluids that may worsen secretions and edema

— Antibiotics for pneumonia when goal is comfort (some hospice patients elect antibiotics for symptomatic relief — individualize)

— Hospital → home hospice: medication reconciliation, equipment delivery (hospital bed, O2, commode), 24/7 contact info, first nurse visit within 24 hours

— SNF → hospice: clarify level of care (routine home care can occur in SNF, but room/board not covered by Medicare hospice benefit — separate payer)

— Hospice → hospital (revocation): clear handoff to inpatient team about prior goals

General inpatient (GIP) hospice level — escalate when:

Continuous home care — escalate when:

Inpatient palliative care consult (before hospice or for non-terminal serious illness):

When NOT to escalate (common Step 3 wrong answers in late-stage hospice patient):

Hospice revocation: patient or surrogate may revoke at any time to pursue curative care; document carefully — they may re-elect later.

Transitions of care risks (Step 3 favorite):

CCS pearl: When advancing the clock on a hospice patient with new severe pain crisis, order GIP-level hospice admission for symptom control rather than acute care hospitalization — protects the goals of care.

Key Differentials — Other End-of-Life Care Models

— Any stage of serious illness, no prognosis requirement, concurrent with curative therapy

— Provided in outpatient clinics, inpatient consults, or community-based

— Best for: newly diagnosed metastatic cancer on chemo, advanced HF awaiting LVAD, ESRD weighing dialysis, post-stroke goals clarification

— Symptom management and basic GOC conversations provided by the primary team (family physician, oncologist, hospitalist)

— Step 3 expects family physicians to deliver this competently and refer to specialty palliative care when complex

— Patient/family choose comfort measures during a hospital admission without formal hospice enrollment (e.g., dying overnight with no time to enroll)

— All comfort interventions but billed under acute care

— Skilled intermittent nursing/therapy for homebound patients with rehabilitative or restorative goals under Medicare Part A

— Time-limited; requires expected improvement

— Cannot bill home health and hospice simultaneously for the same condition

— Custodial nursing home care not covered by Medicare beyond 100 days post-qualifying hospital stay; Medicaid covers for eligible patients

— Hospice services can be added concurrently in SNF (Medicare pays hospice; patient/Medicaid pays room & board)

— Legal in select US jurisdictions (OR, WA, VT, CA, CO, HI, NJ, NM, ME, DC, MT via court ruling) with strict criteria: terminally ill adult, capacity, voluntary, two physicians, waiting periods, self-administration

— Ethically and operationally distinct from hospice and palliative sedation; hospice agencies set their own policies on participation

Hospice is one of several end-of-life care pathways. Knowing alternatives prevents Step 3 traps.

Palliative care (specialty consultative):

Primary (generalist) palliative care:

Comfort-focused inpatient care (no hospice election):

Home health (NOT hospice):

Long-term care/SNF/custodial care:

Physician-assisted death (medical aid in dying):

Key distinction: Palliative care ≠ hospice. A patient on chemotherapy with metastatic NSCLC can have palliative care comanagement but is not yet hospice-eligible until disease-directed therapy is discontinued and prognosis is ≤6 months.

Key Differentials — Conditions Mimicking Hospice-Appropriate Decline

— May present as anorexia, weight loss, withdrawal, "giving up," requests to die

— PHQ-9 or single-item screen: "Are you depressed?" has decent sensitivity in advanced illness

— Treat with SSRI (sertraline, citalopram with QTc caution) or methylphenidate for rapid effect in short-prognosis patients

— Treated depression often reframes goals; never assume preference for hospice reflects unmodified depression

— UTI, medication toxicity (anticholinergics, benzodiazepines, opioids), hypercalcemia, hyponatremia, urinary retention, fecal impaction

— Reverse before attributing decline to underlying disease

— TSH, B12, folate, depression screen, dental/swallow eval, social/financial barriers to food, medication review, dementia evaluation

— Reversible contributors are common

— Cumulative anticholinergic burden, hypoglycemia from tight DM control, orthostasis from over-titrated antihypertensives can mimic terminal frailty

— Deprescribing trial may restore function

— Sometimes "patient is failing" reflects caregiver exhaustion or housing instability rather than disease progression; social work assessment is essential

— Mandatory reporting to Adult Protective Services in all states for suspected abuse, neglect, exploitation

— Distinguish abuse-related decline from disease trajectory

Not every decline equals terminal illness. Recognize reversible mimics before defaulting to hospice.

Depression in the elderly or seriously ill:

Delirium from reversible causes:

Failure-to-thrive workup before "terminal" label:

Hypoactive heart failure exacerbation, COPD exacerbation, anemia, occult malignancy — may mimic end-stage decline; targeted treatment can restore function

Polypharmacy and overtreatment:

Caregiver crisis vs. patient decline:

Elder mistreatment or self-neglect:

Anorexia nervosa or severe depression with food refusal in older adults — rare but consider before terminal categorization

Step 3 management: Before recommending hospice for an elderly patient with weight loss and fatigue, complete a reversibility workup — depression screen, medication review, basic labs (CBC, CMP, TSH, B12). If reversible, treat; if exhausted and disease-driven, transition to hospice discussion.

Board pearl: Untreated depression is the single most important reversible diagnosis to exclude before accepting a patient's request to "stop everything."

Longitudinal Plan — Bereavement, Family Support, and After-Death Care

— Up to 13 months of bereavement support for family/caregivers after patient's death

— Includes phone calls, mailings, support groups, individual counseling, memorial services

— Identifies and refers complicated/prolonged grief disorder for specialty mental health care

— Persistent yearning, identity disruption, avoidance, emotional pain, difficulty re-engaging >12 months after loss (>6 months in children)

— Risk factors: sudden/violent death, close kinship, caregiver burden, prior mental illness, lack of social support

— Treatment: complicated grief therapy (Shear protocol), CBT; SSRIs limited evidence except for comorbid depression

— Normal process during dying; family meetings, life review, legacy work (letters, recordings) help

— Hospice typically arranges pronouncement (RN in many states; MD in some); no 911 needed if expected death

— Family allowed time with body before funeral home transfer

— Autopsy generally not required for expected hospice deaths; coroner referral for unexpected deaths, violent/suspicious circumstances, deaths within 24 hours of admission (varies by jurisdiction)

— Completed by attending or hospice physician; cause of death is the underlying disease (e.g., "metastatic pancreatic adenocarcinoma"), not the mode (e.g., not "cardiopulmonary arrest")

— Condolence call/card within first week

— Offer bereavement follow-up visit at 1–3 months

— Screen surviving spouse for depression, suicidality, complicated grief, and address their own health maintenance

— Widowhood effect: increased mortality in surviving spouse, especially first 6 months — proactive engagement matters

Bereavement services (Medicare-mandated hospice benefit):

Complicated grief / prolonged grief disorder (DSM-5-TR):

Anticipatory grief:

Pronouncement and after-death care:

Death certificate:

Family physician role post-death:

Step 3 management: A widow presents 9 months after her husband's death with persistent yearning, social withdrawal, and inability to return to work — screen for prolonged grief disorder and refer for complicated grief therapy; co-treat any depression.

Board pearl: Bereavement is a covered hospice benefit for families for 13 months after death — utilize it proactively, not only on request.

Follow-Up, Recertification, and Quality Monitoring

— Initial certification: attending + hospice medical director, ≤6-month prognosis

— Benefit periods: two 90-day → unlimited 60-day

— Face-to-face encounter: required by hospice physician or NP before the 3rd benefit period and each subsequent period to verify continued eligibility

— Nurse case manager visits typically 1–3 times/week; aide for personal care; social work and chaplaincy as needed; MD visits per plan

— Not failure — accurate prognostication is imperfect; ~15–20% of hospice enrollees are discharged alive

— Document continued vs. resolved eligibility; if no longer meeting criteria, discharge with transition plan to home health or primary care

— Patient retains right to re-elect hospice when criteria again met

— Symptom scores (Edmonton Symptom Assessment System — ESAS) at each visit: pain, fatigue, nausea, depression, anxiety, drowsiness, appetite, well-being, dyspnea

— Functional status (PPS) trended

— Bowel function, hydration/skin integrity, pressure injury risk (Braden)

— Caregiver capacity and burnout (Zarit Burden Interview if formal)

— Medication review at each visit — deprescribe non-comfort meds

— Expected disease trajectory and signs of dying

— How to administer SL/SC PRN medications

— When to call hospice (always first, not 911)

— Decreased oral intake is normal and not painful

— Permission to be present, talk, touch — hearing is the last sense to fade

— PT/OT covered when consistent with goals — fall prevention, transfer training, energy conservation, equipment training (not for restoration of pre-illness function)

— Speech therapy for swallow safety and communication aids

— Quality measures include treatment preferences discussed, beliefs/values addressed, pain screening/management, dyspnea screening, opioid bowel regimen, caregiver experience (CAHPS Hospice Survey)

Hospice longitudinal cadence:

Live discharge from hospice (patient outlives prognosis or improves):

Monitoring parameters during hospice:

Counseling and education to provide families:

Rehab and restorative philosophy within hospice:

Hospice Compare (CMS public reporting):

Step 3 management: A hospice patient with metastatic cancer in benefit period 3 is improving with stable PPS for 6 months — order face-to-face recertification visit; if no longer ≤6-month prognosis, plan live discharge with home health bridge.

Ethical, Legal, and Patient Safety Considerations

— Four elements: understand information, appreciate consequences for self, reason through options, communicate a choice

— Capacity can fluctuate (delirium, sedation); reassess; use the patient's most lucid period

— Lack of capacity ≠ legal incompetence (which is a court determination)

— Living will: documents specific treatment preferences if incapacitated

— Durable healthcare power of attorney (proxy): designates a surrogate decision-maker — generally more flexible and useful than a living will alone

— POLST/MOLST: portable medical orders signed by clinician — actionable across settings (home, EMS, hospital). Designed for seriously ill patients with ≤1-year prognosis. Not a substitute for advance directives in healthy adults

— Step 3 favors POLST for the dying patient in transitions because EMS will honor it; a living will alone often will not be honored by EMS without a portable order

— Apply substituted judgment (what would patient want?) first; best-interest standard only if patient's wishes unknown

— Family disagreements: facilitate via family meeting, ethics consultation; involve risk management for unresolved conflict

— Symptom-relief intervention (e.g., opioid for dyspnea) is ethically permissible even if a foreseen-but-unintended consequence is hastened death, provided the intent is symptom relief, the action itself is not inherently wrongful, the bad effect is not the means to the good effect, and there is proportionate reason

— Suspected elder abuse or neglect must be reported to APS in all states — applies even when patient is on hospice

— Suspected child abuse, certain communicable diseases, gunshot/stab wounds — reportable regardless of end-of-life status

— Med reconciliation at every transition (hospital→home hospice, SNF→hospice); discontinue duplicate or non-goal-concordant meds; verify dosing of new opioids and bowel regimens

— Ensure family has comfort kit (PRN morphine, lorazepam, haloperidol, glycopyrrolate, acetaminophen suppository) and written instructions

Capacity assessment (task-specific, not global):

Advance directives:

Surrogate hierarchy and substituted judgment:

Principle of double effect:

Mandatory reporting:

Transition-of-care safety (Step 3 favorite):

Withdrawing/withholding life-sustaining treatment: ethically and legally equivalent; patient with capacity (or surrogate following known wishes) may decline any treatment including artificial nutrition/hydration and ventilation.

Step 3 management: When a hospice patient with an ICD is enrolled, the immediate ethics-aligned order is arrange ICD deactivation to prevent unwanted painful shocks during dying.

High-Yield Associations and Rapid-Fire Clinical Facts

Hospice = ≤6-month prognosis if disease runs its expected course + election of palliative-only intent (with pediatric concurrent care exception under ACA)

Surprise question: "Would you be surprised if this patient died in the next 12 months?" — No → start GOC conversation

Two physicians certify initial eligibility (attending + hospice medical director)

Benefit periods: two 90-day → unlimited 60-day; face-to-face required before period 3 and beyond

Four levels of care: routine home, continuous home, GIP, respite (max 5 days)

Bereavement coverage: 13 months for family after death

FAST 7a = dementia hospice entry; requires ≥1 qualifying comorbidity (aspiration PNA, stage 3–4 ulcer, recurrent fever, weight loss >10%, albumin <2.5)

NYHA IV + optimal therapy = heart failure hospice criterion (EF supportive, not required)

PEG tubes do NOT benefit advanced dementia (AGS strong recommendation against)

Morphine = first-line opioid; avoid in CrCl <30 (use fentanyl or hydromorphone)

Low-dose opioids = first-line for dyspnea; fan to face is evidence-based

Haloperidol = first-line for terminal delirium; avoid benzodiazepine monotherapy

Glycopyrrolate (peripheral, no CNS) preferred for terminal secretions

Methylnaltrexone for refractory opioid-induced constipation

Always co-prescribe bowel regimen with opioids — no tolerance develops to constipation

ICD deactivation must be offered at hospice enrollment

POLST/MOLST is honored by EMS; a standalone living will often is not

Double-effect principle ethically supports symptom-directed opioid/sedative dosing

Live discharge occurs in 15–20% of hospice patients — not failure

Median US hospice LOS ≈17 days; ~25% enroll in last 5 days — late referral is the systemic problem

Earlier palliative/hospice care = equal or longer survival + better QOL (Temel 2010)

Pediatric concurrent care (ACA Section 2302): children can receive hospice + curative care simultaneously

Mandatory APS reporting applies even during hospice

Board pearl: If a Step 3 stem asks "what is the next best step" for an advanced-illness patient with declining function, recurrent admissions, and family asking "what now?" — the answer is almost always goals-of-care conversation followed by hospice referral.

Board Question Stem Patterns

Stem 1 — Late-stage cancer outpatient visit: 68 y/o with metastatic pancreatic cancer, ECOG 3, 15% weight loss, declining further chemo, lives with spouse. Next step? → Refer to hospice. Distractors: order PET/CT, start second-line chemo, refer for clinical trial, admit for IV nutrition.

Stem 2 — Advanced dementia with aspiration pneumonia: 84 y/o, FAST 7c, recurrent aspiration PNA × 3 in 6 months, weight loss 12%, family asks about feeding tube. Best recommendation? → Counsel against PEG; refer to hospice. Distractors: place PEG, video swallow study, speech therapy alone.

Stem 3 — End-stage heart failure: NYHA IV, EF 15%, on optimal GDMT, 4 admissions in 6 months, ICD in place, says "I don't want to come back." Next step? → Hospice referral + ICD deactivation discussion. Distractors: LVAD evaluation (if specifically not a candidate), uptitrate diuretic alone, admit for milrinone.

Stem 4 — ESRD off dialysis: 79 y/o declines hemodialysis, Cr 9, declining function. → Hospice eligible. Distractors: mandatory dialysis initiation, peritoneal dialysis without GOC.

Stem 5 — Opioid management in CKD: Hospice patient on morphine develops myoclonus and confusion, CrCl 22. Next step? → Rotate to fentanyl or hydromorphone (M6G accumulation). Distractors: increase morphine, add benzodiazepine.

Stem 6 — Dyspnea in end-stage COPD on hospice: Severe dyspnea despite O2. Best next step? → Low-dose oral morphine ± fan to face. Distractors: BiPAP initiation, ED transfer, increase O2 flow to high level.

Stem 7 — Family conflict: Patient with capacity wants hospice; adult children insist on "doing everything." → Honor the patient's wishes; facilitate family meeting; ethics consult if unresolved.

Stem 8 — Terminal delirium: Agitated hospice patient. First-line? → Haloperidol low-dose; rule out reversibles (retention, impaction, pain). Distractor: lorazepam monotherapy.

Stem 9 — Pediatric advanced cancer on chemo: Family asks about hospice while continuing curative chemo. → Pediatric concurrent care under ACA allows both.

Stem 10 — Live discharge: Hospice patient stable for 9 months, PPS now 70%. → Recertification face-to-face; if no longer eligible, live discharge with transition plan.

Stem 11 — POLST vs. living will: Patient at home with living will only; EMS arrives during arrest. → EMS may not honor living will; POLST/MOLST is the actionable order.

Stem 12 — Bereavement: 10 months after spouse's hospice death, surviving spouse with persistent yearning and functional impairment. → Prolonged grief disorder; refer for complicated grief therapy.

Step 3 management: Recognize the "What is the most appropriate next step" stem in advanced illness — the right answer is almost never another diagnostic test.

One-Line Recap

Hospice is the Medicare benefit for patients with a ≤6-month prognosis who elect comfort-focused care, and the family physician's role on Step 3 is to recognize eligibility early, lead the goals-of-care conversation, and execute a timely, well-documented referral with continuity through bereavement.

Eligibility: ≤6-month prognosis if disease follows expected course + election of palliative intent; two-physician certification; diagnosis-specific LCD criteria (FAST 7a + comorbidity for dementia, NYHA IV for HF, FEV1 <30% with cor pulmonale for COPD, Child-Pugh C non-transplant for liver, CrCl <10–15 off dialysis for renal, ECOG ≥3 with advanced cancer).

Trigger to act: the surprise question ("Would I be surprised if this patient died in 12 months?"); declining PPS; recurrent admissions; patient statements of "no more hospital." The correct Step 3 next step is a structured goals-of-care conversation (SPIKES, Ask-Tell-Ask, NURSE) followed by hospice referral — not another imaging study or escalation of disease-directed therapy.

Symptom toolkit: morphine first-line for pain and dyspnea (fentanyl/hydromorphone in renal impairment), haloperidol for terminal delirium and nausea, glycopyrrolate for secretions, scheduled senna + PEG with every opioid, methylnaltrexone for refractory opioid constipation; always offer ICD deactivation and avoid PEG in advanced dementia.

Systems and ethics: POLST/MOLST is the portable, EMS-honored order; pediatric concurrent care under ACA allows kids to receive hospice plus curative therapy; bereavement is covered 13 months post-death; live discharge occurs in 15–20% and is not failure; mandatory APS reporting applies even in hospice; the principle of double effect ethically supports proportionate symptom-directed opioid and sedative use.

Board pearl: Earlier hospice = better symptom control, lower caregiver distress, and equal or longer survival — referring sooner is the higher-quality, more guideline-concordant, and exam-correct answer.